OKUR today
$3.15-$0.21 (-6.25%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $2.47
Key levels
Resistance$3.52
Resistance$3.24
Support$2.72
Support$2.31
Latest news & SEC filings
EarningsOnKure Therapeutics Posts Q3 2026 Results
EarningsOnKure Therapeutics posts wider Q3 loss than expected
SEC FilingOnKure Therapeutics, Inc. filed a report on a major company event (Form 8-K)
All OKUR news →About OnKure Therapeutics
OnKure Therapeutics creates precision therapies aimed at particular genetic changes that fuel tumor growth and certain non-cancer conditions. Its lead drug, OKI-219, is taken by mouth and is designed to act on a specific PI3Kα mutation while mostly avoiding the unmutated version of that protein. Testing of OKI-219 is underway in an early-phase study enrolling people with advanced malignancies, such as breast tumors, and the company also has discovery efforts focused on other PI3Kα mutations and vascular abnormalities.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
OnKure Therapeutics, Inc. (OKUR)
What Is the Price Target for OKUR?
SEPT Low Target
$11.90
SEPT Mid Target
$14.00
SEPT High Target
$16.10
Analyst Consensus
$14.00
Is OKUR a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OKUR.
Start Free Trial →Is OKUR Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$11.03
17
Moat Score
NONE
2/9
Piotroski Score
-4.2
Altman Z-Score
What Is Smart Money Doing with OKUR?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Saccomano Nicholas A | director officer | Sale | 87 | $258.76 | Sep 21, 2026 |
| Leverone Jason A. | officer | Sale | 302 | $898.21 | Sep 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →OKUR Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
71.2%
FCF Growth YoY
-1.4%
Revenue Trend
UNKNOWN
Dark Pool Trades for OKUR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for OKUR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:48:56 | $3.15 | 1,240 | $$4K | SELL |
| 19:38:52 | $3.50 | 2,000 | $$7K | BUY |
| 19:22:15 | $3.51 | 1,800 | $$6K | MIDPOINT |
| 19:22:15 | $3.51 | 2,430 | $$9K | MIDPOINT |
| 19:03:08 | $3.57 | 1,400 | $$5K | MIDPOINT |
5 dark pool trades shown · $$31K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for OnKure Therapeutics, Inc. (OKUR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →OKUR — frequently asked questions
What is OKUR stock price today?
OnKure Therapeutics, Inc. (OKUR) is at $3.15, down 6.25% (-$0.21) at the Nov 12, 2026 close.
Why is OKUR stock moving today?
Latest OKUR news — Nov 5, 2026: OnKure Therapeutics Posts Q3 2026 Results · Nov 4, 2026: OnKure Therapeutics posts wider Q3 loss than expected
What is the OKUR price target?
The average analyst price target for OKUR is $14.00, ranging from $14 to $14, based on 1 analysts.
What do analysts rate OKUR?
Analyst ratings for OKUR: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did OKUR beat earnings?
OKUR last reported on Aug 4, 2026: EPS -$0.31 vs -$0.54 expected — a beat of 42.1%.
Does OKUR pay a dividend?
OKUR does not currently pay a dividend.
What are OKUR support and resistance levels?
Support: $2.72, $2.31, $2.01. Resistance: $3.24, $3.52, $3.83.
What are insiders doing with OKUR?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on OKUR?
Nov 5, 2026: OnKure Therapeutics Posts Q3 2026 Results · Nov 4, 2026: OnKure Therapeutics posts wider Q3 loss than expected · Nov 4, 2026: OnKure Therapeutics, Inc. filed a report on a major company event (Form 8-K)